Latest Health News

Tag: paving-the-way

  • Dynavax to resubmit hep B vaccine for approval after positive data

    —

    by

    publisher
    in

    Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study, paving the way for the company to resubmit its marketing application. The earlier marketing application for the vaccine, HEPLISAV-B, was rejected in February 2013 by the U.S. Food and Drug Administration (FDA), which sought additional…

  • Dynavax to resubmit hep B vaccine for approval after positive data

    —

    by

    contributor
    in

    Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study, paving the way for the company to resubmit its marketing application. The earlier marketing application for the vaccine, HEPLISAV-B, was rejected in February 2013 by the U.S. Food and Drug Administration (FDA), which sought additional…

  • The Best Diet Ever: Three Key Ingredients

    —

    by

    contributor
    in

    As weight loss and maintenance is one of my specialties, I am often asked, “What is the best diet?” People are often disappointed by my response. I tell them, “The best diet meets three conditions:It's a healthy diet.It's a diet that includes your favorite foods, in moderation, even if they're not entirely healthy.It's a diet…

  • The Best Diet Ever: Three Key Ingredients

    —

    by

    publisher
    in

    As weight loss and maintenance is one of my specialties, I am often asked, “What is the best diet?” People are often disappointed by my response. I tell them, “The best diet meets three conditions:It's a healthy diet.It's a diet that includes your favorite foods, in moderation, even if they're not entirely healthy.It's a diet…

  • Medellin: The Right Place and Time for Collaborative Learning in Public Health

    —

    by

    elegant
    in

    by Negeen Darani, Harvard Humanitarian InitiativePhoto by Kevin Dooley. Today marks Day 2 of the Post-Conflict Colombia and Public Health course — a project of the Open Hands Initiative and Harvard Humanitarian Initiative (HHI), in collaboration with the University of Antioquia School of Medicine. Sixteen students from the Harvard T.H. Chan…

  • J&J leukemia drug cuts death risk vs. chemo in new patients: study

    —

    by

    publisher
    in

    Johnson & Johnson’s and AbbVie’s cancer drug Imbruvica significantly reduced the risk of death and disease progression compared with chemotherapy in previously untreated patients with a type of leukemia in a late stage study, paving the way for an expanded approval of the medicine. In the trial of 269 patients aged 65 and older with…

  • Novartis trial shows drug improves survival for AML patients

    —

    by

    elegant
    in

    ZURICH (Reuters) – Novartis' phase III study for its acute myeloid leukemia (AML) drug showed it improved overall survival by 23 percent for patients with FLT3 mutations, the Swiss drugmaker said on Sunday. Basel-based Novartis said the study was the first large controlled trial to show overall survival benefit in FLT3-mutated AML, and that worldwide…